Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
May 2006
2006:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2007 | 2008
News | News in brief | News Features
News
Synthetic biologists try to calm fears
Researchers in the field are to issue a declaration of intent in order to ensure good practice and to address a range of concerns about their work.
Nature (25th May)
| Full Text |
Election fever inflames the US stem-cell debate
In the run-up to autumn's Senate elections, stem-cell research has become something of a political football.
Nature (25th May)
| Full Text |
Named and shamed
As accusations of scientific misconduct in China become rife, some fear persecution reminiscent of that used in the Cultural Revolution.
Nature (25th May)
| Full Text |
Antibiotic faces uncertain future
A promising new antibiotic is generating both excitement and despondency.
Nature (18th May)
| Full Text |
Neanderthal DNA yields to genome foray
Genetic material sequenced from a 45,000-year-old male has geneticists excited about the idea of sequencing a Neanderthal genome.
Nature (18th May)
| Full Text |
How does a painkiller harm the heart?
Two data sets published this month shed light on where Vioxx went wrong.
Nature (18th May)
| Full Text |
Are rich nations up for drug reform?
This month the World Health Organization (WHO) will consider two proposals aimed at reshaping the forces that drive medical research and development.
Nature (11th May)
| Full Text |
Avian flu and the New World
The H5N1 avian influenza virus has not yet reached North and South America. What will happen when it does?
Nature (11th May)
| Full Text |
State's flu response raises concern
Official alerts play down possible H5 strain found in a live-bird market in New Jersey.
Nature (11th May)
| Full Text |
Tuft's report backs FDA fast-track, but post-marketing concerns loom
A new report fromTufts University, Boston, suggests that the pressure has let up and that the fast-track program has sped drug approvals.
Nature Biotechnology (May 2006)
| Full Text |
Stem cell controversy to stall European tissue and cell therapy rules
Divergent views among European Union member states on human embryonic stem cell research could hamper the creation of a much awaited new regulatory framework to address the sale and marketing of cell therapies and tissue-engineered products.
Nature Biotechnology (May 2006)
| Full Text |
Will medics' qualms kill the death penalty?
Could the medical community's refusal to assist help end the practice?
Nature (4th May 2006)
| Full Text |
Chemists get out begging bowl to avert closure
Plan to close the chemistry department at the University of Sussex, Brighton, attracts international criticism.
Nature (4th May 2006)
| Full Text |
Trial set to test how stem cells heal a broken heart
Injecting stem cells gives damaged hearts a boost, perhaps by providing fresh mitochondria.
Nature Medicine (May 2006)
| Full Text |
Sheep study calls for closer look at prion hypothesis
A controversial report claims that prions may not cause mad cow disease or scrapie.
Nature Medicine (May 2006)
| Full Text |
Cell-based tests tackle predicting safety of antibody drugs
The disastrous trial in the UK in March has raised serious concerns about the adequacy of the preclinical tests routinely used during the development of new drugs.
Nature Medicine (May 2006)
| Full Text |
News in brief
Congress wants more cash for health, less for nuclear
| Study heightens fears of second wave of vCJD
| NIH taken to court over proposed biodefence lab
| Italy appoints chemist in bid to embrace science
| Sussex saves threatened chemistry department
|Australian budget builds on health research
| Glaxo shareholders win protection from extremists
| Disgraced cloner accused of embezzling grants
| Senators want public access for all research papers
| Japan creates prize for work on African diseases
| European grant ensures free data for biologists
| United States gives Iraq a virtual science library
| Drug safety data sharing
| Microsoft backs bioinformatics
| EMEA, FDA, parallel advice continued
| Regulator seeks cause of death in gene-therapy trial
| Top US scientists publicly condemn Guantanamo
| Medical journals told to advertise goods not drugs
| Pigs to produce healthy fats
| Extreme drug resistance to tuberculosis emerges
News Features
Genetics: What is a gene?
The idea of genes as beads on a DNA string is fast fading. Protein-coding sequences have no clear beginning or end and RNA is a key part of the information package.
Nature (25th May 2006)
| Full Text |
Animal intelligence
Use of animals for testing early in the drug-development process aims to provide vital information to make new drugs safe and effective - and the process is being constantly refined.
Nature (25th May 2006)
| Full Text |
Visual neuroscience: Look and learn
Prevailing wisdom says the adult brain cannot learn to see if it had no visual stimulation during childhood, but blind people in India seem to be breaking all the rules.
Nature (18th May 2006)
| Full Text |
Microbiology: Batteries not included
Among their many talents, bacteria are the world's best electrochemists, creating a life-powering flow of electrons in a startling range of conditions.
Nature (18th May 2006)
| Full Text |
International view from Japan
Kyoto students reach out for international collaborators.
Nature (18th May 2006)
| Full Text |
Epigenetics: Unfinished symphony
To correctly 'play' the DNA score in our genome, cells must read another notation that overlays it — the epigenetic code.
Nature (May 2006)
| Full Text |
Gold in the ivory tower: equity rewards of outlicensing
An analysis of life-science initial public offerings from three time periods reveals that the equity share received by universities and their academic researchers has changed over time.
Nature Biotechnology (May 2006)
| Full Text |
Biomedical research: Facing the opposition
Elias Zerhouni has one of the biggest jobs in biomedical research – running the massive US National Institutes of Health. But is he leading the agency up the right path?
Nature (4 May 2006)
| Full Text |
It's a postdoc's life
Does the respected US National Institutes of Health meet the needs of young postdoc researchers?
Nature (4 May 2006)
| Full Text |
Misconduct mayhem
Thinking about scientific misconduct before tangling with a real case will help you protect your own career and promote research integrity.
Nature (4 May 2006)
| Full Text |
|
